Cohen & Steers’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
Cohen & Steers's REGN Position: Q3 2026 in Review
Cohen & Steers held its Regeneron Pharmaceuticals (REGN) position steady in Q3 2026 at 130 shares worth $99K. The position accounts for ﹤0.01% of the portfolio, ranked #414.
Cohen & Steers first reported a position in REGN in Q1 2025 and has held it in 7 quarters since. The position peaked at $100K in Q1 2026. 1,426 funds tracked by Wall St. Rank hold REGN as of Q3 2026.
- Cohen & Steers held 130 shares of Regeneron Pharmaceuticals worth $99K as of Q3 2026.
- Cohen & Steers left its Regeneron Pharmaceuticals share count unchanged in Q3 2026.
- Regeneron Pharmaceuticals made up ﹤0.01% of Cohen & Steers's portfolio in Q3 2026, its #414 holding.
- Cohen & Steers first reported a position in Regeneron Pharmaceuticals in Q1 2025 and has held it in 7 quarters since.
- Cohen & Steers's Regeneron Pharmaceuticals position peaked at $100K in Q1 2026.
- 1,426 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2026.
Based on Cohen & Steers's 13F filing for Q3 2026, filed 16 Nov 2026.